Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;142(2):261-6.
doi: 10.1016/j.ygyno.2016.05.024. Epub 2016 Jun 1.

Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012

Soledad Jorge  1 , Nathaniel L Jones  1 , Ling Chen  2 , June Y Hou  3 , Ana I Tergas  4 , William M Burke  3 , Cande V Ananth  5 , Alfred I Neugut  6 , Dawn L Herhshman  6 , Jason D Wright  7
Affiliations

Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012

Soledad Jorge et al. Gynecol Oncol. 2016 Aug.

Abstract

Objective: To explore the presentation, management and outcomes of adult women diagnosed with immature ovarian teratoma.

Methods: The National Cancer Database (NCDB) was used to identify women≥18years of age diagnosed with an immature teratoma from 1998 to 2012. We analyzed demographic, clinical and tumor characteristics, and treatment trends. Multivariable models were employed to examine predictors of adjuvant chemotherapy use and survival.

Results: We identified a total of 1045 adult women with immature teratoma. The median age of diagnosis was 27years and most were diagnosed between ages 18 and 39 (88.9%). The majority presented with early-stage (I/II) disease (76.0%), underwent unilateral salpingo-oophorectomy (52.5%) and received adjuvant chemotherapy (56.8%). The probability of receiving chemotherapy increased with stage, grade, and treatment at academic compared to community based centers (P<0.05.). Older age, advanced stage, and grade III histology were associated with worse survival (P<0.05). Five-year survival rates were: 98.3% (95% CI 96.8-99.1), 93.2% (95% CI 82.8-97.4), 82.7% (95% CI 74.3-88.5), and 72.0% (95% CI 50.1-85.5) for stages I, II, III, and IV disease, respectively.

Conclusions: The incidence of immature teratoma is highest in young adults aged 18 to 39. Most patients present with early-stage disease, are managed with fertility sparing surgery and chemotherapy and have an excellent prognosis. Later age at diagnosis, advanced stage, and high-grade histology confer a worse prognosis.

Keywords: Immature teratoma; Ovarian cancer; Ovarian carcinoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Kaplan-Meier analysis of survival for women with stage I (Figure 1A) and stages II–IV (Figure 1B) immature teratoma.
Figure 1
Figure 1
Kaplan-Meier analysis of survival for women with stage I (Figure 1A) and stages II–IV (Figure 1B) immature teratoma.
See this image and copyright information in PMC

References

    1. Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000;95(1):128–133. - PubMed
    1. Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075–1085. - PubMed
    1. Hinchcliff E, Rauh-Hain JA, Clemmer JT, Diver E, Hall T, Stall J, et al. Racial disparities in survival in malignant germ cell tumors of the ovary. Gynecol Oncol. 2016 - PubMed
    1. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976;37(5):2359–2372. - PubMed
    1. Morgan RJ, Jr, Alvarez RD, Armstrong DK, Burger RA, Chen LM, Copeland L, et al. Ovarian cancer, version 2.2013. J Natl Compr Canc Netw. 2013;11(10):1199–1209. - PubMed

Supplementary concepts